Table 3.
Reported cases of cytokine storm syndrome (including sHLH/MAS) treated with intravenous anakinra
Patient details | Underlying diagnosis | IV anakinra | Other acute management | Maintenance | Length of follow-up (months) | |
---|---|---|---|---|---|---|
Chou et al (2010)61 | 36-year-old female | MDS | Details not specified | Corticosteroids 1 mg/kg per day | Anakinra (assumed SC); prednisolone 40 mg/day | 2 |
Nigrovic et al (2011);62 Record et al (2011)63 | 4-year-old female | sJIA, diagnosed at 8 months of age | 11·2 mg/kg per day (5·6 mg/kg twice a day); duration unspecified | Corticosteroids 1·1 mg/kg per day; MTX; 0·8 mg/kg per week | Anakinra 0·9 mg/kg per day (assumed SC); steroids 0·9 mg/kg per day; MTX 0·7 mg/kg per week; abatacept IV 0·3mg/kg per 3 weeks | 24 |
Loh et al (2012)64 | 20-year-old male | AOSD | 200 mg once daily for 6 days | Methylprednisolone; IV hydrocortisone; CSA 100 mg twice daily | Anakinra 100 mg SC; once-daily; MTX 10 mg once-weekly | Unknown |
Acker et al (2015)65 | 22-month-old male | Septic arthritis | Details not specified | Prednisolone oral | Anakinra (assumed SC) | 24 |
Kemps et al (2017)66 | 71-year-old male | CMV and AAV | 400 mg every 3 days for 10 days | Not specified | Not specified | Unknown |
Eloseily et al (2020)41 | 19-year-old female | SLE | 48 mg/kg per day for 3 days | Not specified | Not applicable | Died |
Eloseily et al (2020)41 | 8-year-old male | HHV-6 | 8–48 mg/kg per day for 1 month | Etoposide; dexamethasone; solumedrol; CSA 4 mg/kg per day | Not applicable | Died |
Eloseily et al (2020)41 | 16-year-old female | Gastroparesis and CMV | 4–48 mg/kg per day for 3 months | Methylprednisolone; CSA 4 mg/kg per day; abatacept; tocilizumab | Not applicable | Died |
MDS=myelodysplastic syndrome. SC=subcutaneous. sJIA=systemic juvenile idiopathic arthritis. MTX=methotrexate. AOSD=adult-onset Still's disease. IV=intravenous. CSA=ciclosporin. CMV=cytomegalovirus. AAV=ANCA-associated vasculitis. SLE=systemic lupus erythematosus. HHV-6=human herpes virus-6.